Breast Cancer

Metastatic Right Breast Carcinoma

Female, 46 years

Patient Internal ID: 183594467

ICD-10 code

C50.8 Malignant Neoplasm of Overlapping Lesions of Breast

Diagnosis (Incl. Metastases/Stage) and Year

June 2016
Breast Cancer (Right Side) pT2N1miM1 ER (-), PR (-), HER2 (-) (triple-negative) Poorly Differentiated (G3) Metastasis in Hepatis. May 2020 – Metastasis in Bone.

Previous Treatment

Surgery – Quadrantectomy of the Right Breast. Chemotherapy (Docetaxel and Doxorubicin), Chemotherapy (Paclitaxel), Chemotherapy (Nab-paclitaxel), Immunotherapy (Atezolizumab), Chemotherapy (Abemaciclib), Radiation Therapy.

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of 13.3 months from diagnosis.

Treatment Provided

Autologous DCV (10 doses) and CIK (6 doses) over a period of 52 months.

Patient Survival/Condition and Year
Date of Review: 31/01/2024

The patient has survived for 90 months since the diagnosis. It can be concluded that the addition of Immunotherapy, alongside Chemotherapy, Surgery and Radiation Therapy has extended patient survival by an estimate of around 77 months and greatly contributed to disease control.